These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26247579)

  • 1. Medication adherence and measures of health plan quality.
    Seabury SA; Lakdawalla DN; Dougherty JS; Sullivan J; Goldman DP
    Am J Manag Care; 2015 Jun; 21(6):e379-89. PubMed ID: 26247579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs.
    Esposito D; Bagchi AD; Verdier JM; Bencio DS; Kim MS
    Am J Manag Care; 2009 Jul; 15(7):437-45. PubMed ID: 19589011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacy effect on adherence to antidiabetic medications.
    Sharma KP; Taylor TN
    Med Care; 2012 Aug; 50(8):685-91. PubMed ID: 22354211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data.
    Karve S; Cleves MA; Helm M; Hudson TJ; West DS; Martin BC
    Curr Med Res Opin; 2009 Sep; 25(9):2303-10. PubMed ID: 19635045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic disease medication use in managed care and indemnity insurance plans.
    Stafford RS; Davidson SM; Davidson H; Miracle-McMahill H; Crawford SL; Blumenthal D
    Health Serv Res; 2003 Apr; 38(2):595-612. PubMed ID: 12785563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure.
    Bagchi AD; Esposito D; Kim M; Verdier J; Bencio D
    Clin Ther; 2007 Aug; 29(8):1771-83. PubMed ID: 17919558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of type 2 diabetes medication cost sharing on patient outcomes and health plan costs.
    Thornton Snider J; Seabury S; Lopez J; McKenzie S; Goldman DP
    Am J Manag Care; 2016 Jun; 22(6):433-40. PubMed ID: 27355811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis.
    Pelletier EM; Pawaskar M; Smith PJ; Best JH; Chapman RH
    J Med Econ; 2012; 15(6):1039-50. PubMed ID: 22533526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of medication adherence on health outcomes for chronic metabolic diseases: a retrospective cohort study.
    Han E; Suh DC; Lee SM; Jang S
    Res Social Adm Pharm; 2014; 10(6):e87-e98. PubMed ID: 25088545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does good medication adherence really save payers money?
    Stuart BC; Dai M; Xu J; Loh FH; S Dougherty J
    Med Care; 2015 Jun; 53(6):517-23. PubMed ID: 25961659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician-specific variation in medication adherence among diabetes patients.
    Sherman BW; Sekili A; Prakash ST; Rausch CA
    Am J Manag Care; 2011 Nov; 17(11):729-36. PubMed ID: 22084892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of a value-based insurance design plus health coaching on medication adherence and medical spending.
    Musich S; Wang S; Hawkins K
    Popul Health Manag; 2015 Jun; 18(3):151-8. PubMed ID: 25247449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.
    Simoni-Wastila L; Wei YJ; Qian J; Zuckerman IH; Stuart B; Shaffer T; Dalal AA; Bryant-Comstock L
    Am J Geriatr Pharmacother; 2012 Jun; 10(3):201-10. PubMed ID: 22521808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of medication supply on hospitalizations and health-care costs in patients with chronic heart failure.
    Dilokthornsakul P; Chaiyakunapruk N; Nimpitakpong P; Jeanpeerapong N; Sruamsiri R
    Value Health; 2012; 15(1 Suppl):S9-14. PubMed ID: 22265074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication adherence as a measure of the quality of care provided by physicians.
    Seabury SA; Dougherty JS; Sullivan J
    Am J Manag Care; 2019 Feb; 25(2):78-83. PubMed ID: 30763038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of value-based insurance design with a large retail employer.
    Kim YA; Loucks A; Yokoyama G; Lightwood J; Rascate K; Serxner SA
    Am J Manag Care; 2011 Oct; 17(10):682-90. PubMed ID: 22106461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mail-order pharmacy use and medication adherence among Medicare Part D beneficiaries with diabetes.
    Zhang L; Zakharyan A; Stockl KM; Harada AS; Curtis BS; Solow BK
    J Med Econ; 2011; 14(5):562-7. PubMed ID: 21728913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
    Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
    Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.
    Cole JA; Norman H; Weatherby LB; Walker AM
    Pharmacotherapy; 2006 Aug; 26(8):1157-64. PubMed ID: 16863491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of value-based benefit design on adherence to diabetes medications: a propensity score-weighted difference in difference evaluation.
    Zeng F; An JJ; Scully R; Barrington C; Patel BV; Nichol MB
    Value Health; 2010; 13(6):846-52. PubMed ID: 20561344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.